Annual Total Liabilities
$68.78 M
-$2.44 M-3.43%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual total liabilities is $68.78 million, with the most recent change of -$2.44 million (-3.43%) on December 31, 2023.
- During the last 3 years, STOK annual total liabilities has risen by +$56.93 million (+480.54%).
- STOK annual total liabilities is now -3.43% below its all-time high of $71.22 million, reached on December 31, 2022.
Performance
STOK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$61.21 M
-$3.84 M-5.91%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly total liabilities is $61.21 million, with the most recent change of -$3.84 million (-5.91%) on September 30, 2024.
- Over the past year, STOK quarterly total liabilities has dropped by -$5.68 million (-8.50%).
- STOK quarterly total liabilities is now -20.62% below its all-time high of $77.11 million, reached on June 30, 2022.
Performance
STOK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
STOK Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.4% | -8.5% |
3 y3 years | +480.5% | -8.5% |
5 y5 years | +2683.4% | -8.5% |
STOK Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.4% | +226.1% | -20.6% | +190.2% |
5 y | 5-year | -3.4% | +1491.3% | -20.6% | +1316.2% |
alltime | all time | -3.4% | +2683.4% | -20.6% | +2377.0% |
Stoke Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $61.21 M(-5.9%) |
Jun 2024 | - | $65.05 M(+0.3%) |
Mar 2024 | - | $64.84 M(-5.7%) |
Dec 2023 | $68.78 M(-3.4%) | $68.78 M(+2.8%) |
Sep 2023 | - | $66.89 M(+0.2%) |
Jun 2023 | - | $66.72 M(-1.8%) |
Mar 2023 | - | $67.97 M(-4.6%) |
Dec 2022 | $71.22 M(+237.7%) | $71.22 M(-3.1%) |
Sep 2022 | - | $73.48 M(-4.7%) |
Jun 2022 | - | $77.11 M(+1.5%) |
Mar 2022 | - | $75.96 M(+260.2%) |
Dec 2021 | $21.09 M | $21.09 M(+29.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $16.26 M(+73.3%) |
Jun 2021 | - | $9.38 M(+45.6%) |
Mar 2021 | - | $6.44 M(-45.6%) |
Dec 2020 | $11.85 M(+174.1%) | $11.85 M(+60.1%) |
Sep 2020 | - | $7.40 M(+8.6%) |
Jun 2020 | - | $6.81 M(+4.8%) |
Mar 2020 | - | $6.50 M(+50.4%) |
Dec 2019 | $4.32 M(+74.9%) | $4.32 M(-16.0%) |
Sep 2019 | - | $5.14 M(+6.4%) |
Jun 2019 | - | $4.84 M(+44.2%) |
Mar 2019 | - | $3.35 M(+35.7%) |
Dec 2018 | $2.47 M(-33.8%) | $2.47 M |
Dec 2017 | $3.73 M | - |
FAQ
- What is Stoke Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Stoke Therapeutics?
- What is Stoke Therapeutics annual total liabilities year-on-year change?
- What is Stoke Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly total liabilities year-on-year change?
What is Stoke Therapeutics annual total liabilities?
The current annual total liabilities of STOK is $68.78 M
What is the all time high annual total liabilities for Stoke Therapeutics?
Stoke Therapeutics all-time high annual total liabilities is $71.22 M
What is Stoke Therapeutics annual total liabilities year-on-year change?
Over the past year, STOK annual total liabilities has changed by -$2.44 M (-3.43%)
What is Stoke Therapeutics quarterly total liabilities?
The current quarterly total liabilities of STOK is $61.21 M
What is the all time high quarterly total liabilities for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly total liabilities is $77.11 M
What is Stoke Therapeutics quarterly total liabilities year-on-year change?
Over the past year, STOK quarterly total liabilities has changed by -$5.68 M (-8.50%)